Jennifer Tousignant, Chief Legal Officer at Viridian Therapeutics, Inc.\DE (VRDN), sold 2,272 shares at $31.16 ($71K) on 2025-12-31, disclosed to the SEC on 2026-01-02.
Open-market sale of $71k VRDN by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.